Extracellular Matrix
Provides a critical prerequisite for successful tissue regeneration, a structure designed to mimic the scaffolding of the extracellular matrix (ECM).
Phoenix Wound Matrix® is a synthetic, fully bioabsorbable advanced wound care device* designed to harness the innate inflammatory response, promote progression to the proliferative phase, and enable the regeneration of functional, native skin in the wound bed.†
The Phoenix Wound Matrix has FDA 510(k) clearance for use in the treatment of both partial- and full-thickness wounds. Wound types include: diabetic ulcers, venous ulcers, pressure ulcers, arterial/ischemic ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Moh's surgery, post laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second degree burns, skin tears) and draining wounds.
*The Phoenix Wound Matrix® is a non-woven, fibrous, electrospun device that is designed to mimic the structure of the extracellular matrix. This is a single use device intended for use in the management of acute and chronic wounds.
Learn More
Dan Shaw
President and Founder Academy Medical
“As a military veteran, I value the opportunity to give back to fellow veterans and active duty personnel alike. Renovoderm is an industry leader in wound care products and our mutual, long-term relationship helps champion our shared commitment of providing service to our nation’s heroes.”
Nanofiber Solutions, LLC is a regenerative medicine company developing a new class of implants with unrivaled performance for the $20B soft tissue/organ repair/regeneration market. NFS’s technology is used to build off-the-shelf scaffolds that are critical in the development of life-saving and life-changing, tissue engineered implants. Their extensive experience working with researchers using their scaffolds in cell culture plates has given them novel insight into the behavior of adherent cells with these scaffolds. Using this knowledge NFS engineers their regenerative medicine products to meet the complex clinical requirements.
